lamivudine has been researched along with bilirubin in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (6.90) | 18.2507 |
| 2000's | 18 (62.07) | 29.6817 |
| 2010's | 9 (31.03) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Benet, LZ; Brouwer, KL; Chu, X; Dahlin, A; Evers, R; Fischer, V; Giacomini, KM; Hillgren, KM; Hoffmaster, KA; Huang, SM; Ishikawa, T; Keppler, D; Kim, RB; Lee, CA; Niemi, M; Polli, JW; Sugiyama, Y; Swaan, PW; Tweedie, DJ; Ware, JA; Wright, SH; Yee, SW; Zamek-Gliszczynski, MJ; Zhang, L | 1 |
| Herrero, JI; Pardo, F; Prieto, J; Quiroga, J; Riezu-Boj, JI; Sangro, B; Sola, I | 1 |
| Yao, FY | 1 |
| Bilodeau, M; Condreay, LD; Fenyves, D; Heathcote, EJ; Leduc, R; Margulies, M; Peltekian, K; Pomier-Layrargues, G; Villeneuve, JP; Willems, B; Wong, F | 1 |
| Arase, Y; Chayama, K; Ikeda, K; Kobayashi, M; Kumada, H; Murashima, N; Saitoh, S; Suzuki, F; Suzuki, Y; Tsubota, A | 1 |
| Chen, CH; Cheng, CH; Lee, WC; Lian, JD; Shu, KH; Wu, MJ | 1 |
| Guan, R; Kajiji, T; Lim, SG; Rajnakova, A; Wai, CT | 1 |
| Chan, FK; Chan, HL; Hui, Y; Leung, NW; Sung, JJ; Tsang, SW | 1 |
| Chien, RN; Liaw, YF; Lin, CH | 1 |
| Ahmet, D; Atilla, O; Cetin, K; Fatih, B; Güngör, B; Kadir, D; Mürüvvet, B; Sabahattin, K; Selim, B; Yilmaz, C; Zeynel, M; Ziyaettin, D | 1 |
| Chao, TY; Dai, MS; Kao, WY; Liu, TM; Shyu, RY | 1 |
| Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Kobayashi, M; Kumada, H; Saitoh, S; Sezaki, H; Someya, T; Suzuki, F; Suzuki, Y; Tsubota, A | 1 |
| Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Kobayashi, M; Kumada, H; Matsuda, M; Saitoh, S; Sato, J; Sezaki, H; Someya, T; Suzuki, F; Suzuki, Y | 1 |
| Chien, RN; Lee, CM; Liaw, YF; Yeh, CT | 1 |
| Canbay, A; Dalekos, GN; Eisenbach, C; Encke, J; Gerken, G; Graziadei, I; Hadem, J; Leifeld, L; Manns, MP; Schmidt, H; Schneider, A; Spengler, U; Tillmann, HL; Vogel, W; Wedemeyer, H; Zachou, K | 1 |
| Jung, JO; Kim, BG; Kim, YJ; Lee, HS; Yoon, JH | 1 |
| Das, K; Hissar, S; Kumar, M; Monga, R; Pande, C; Sarin, SK; Satapathy, S; Sharma, BC | 1 |
| Chang, WY; Chen, SC; Chuang, WL; Dai, CY; Hou, NJ; Hsieh, MY; Huang, JF; Lee, LP; Lin, ZY; Tsai, JF; Wang, LY; Yu, ML | 1 |
| Girke, J; Manns, MP; Tillmann, HL; Wedemeyer, H; Wiegand, J | 1 |
| Hino, T; Hisamochi, A; Ide, T; Koga, H; Koga, Y; Kumashiro, R; Kuwahara, R; Ogata, K; Sata, M; Takao, Y; Tanaka, K | 1 |
| Kang, P; Li, SC; Sun, LJ; Yu, JW; Zhao, YH | 1 |
| Honda, M; Ishisaka, M; Ishizuka, N; Kimura, S; Oka, S | 1 |
| Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Kawamura, Y; Kobayashi, M; Kumada, H; Mori, N; Saito, S; Sezaki, H; Suzuki, F; Suzuki, Y | 1 |
| Hao, CQ; Liu, JF; Wang, M; Zhang, L | 1 |
| Cai, FJ; Ding, JG; Du, QW; Fu, RQ; Hong, L; Sun, QF; Wu, YH; Zhou, QQ | 1 |
| Su, QM; Ye, XG | 1 |
| Bock, CT; Brosteanu, O; Fiedler, GM; Franke, A; Manns, MP; Römmele, U; Rößler, S; Ruf, B; Spengler, U; Teuber, G; Thiery, J; Tillmann, HL; Trautwein, C; Wächtler, M; Wedemeyer, H; Wiegand, J; Zeuzem, S | 1 |
| Li, DC; Lin, CS; Liu, J; Lu, LR; Xu, Z; Zhang, GL | 1 |
3 review(s) available for lamivudine and bilirubin
| Article | Year |
|---|---|
Membrane transporters in drug development.
Topics: Animals; Computer Simulation; Decision Trees; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Drug Interactions; Humans; Membrane Transport Proteins; Mice; Mice, Knockout; Prescription Drugs | 2010 |
Meta-analysis of the short-term effects of lamivudine treatment for severe chronic hepatitis B.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Bilirubin; China; DNA, Viral; Female; Hepatitis B, Chronic; Humans; Lamivudine; Liver Function Tests; Male; Middle Aged; Prothrombin Time; Survival Analysis; Treatment Outcome; Young Adult | 2013 |
Effects of entecavir and lamivudine for hepatitis B decompensated cirrhosis: meta-analysis.
Topics: Adult; Aged; Antiviral Agents; Bilirubin; Biomarkers; Chi-Square Distribution; DNA, Viral; Drug Resistance, Viral; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Middle Aged; Odds Ratio; Prothrombin Time; Serum Albumin; Serum Albumin, Human; Treatment Outcome; Viral Load | 2013 |
9 trial(s) available for lamivudine and bilirubin
| Article | Year |
|---|---|
Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients.
Topics: Adolescent; Adult; Alanine Transaminase; Anti-Inflammatory Agents; Antilymphocyte Serum; Bilirubin; DNA, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Liver Failure; Male; Methylprednisolone; Middle Aged; Prothrombin Time; Treatment Outcome; Virus Activation | 2001 |
The role of lamivudine and predictors of mortality in severe flare-up of chronic hepatitis B with jaundice.
Topics: Adult; Bilirubin; DNA, Viral; Female; Hepatitis Antibodies; Hepatitis B virus; Hepatitis B, Chronic; Humans; Jaundice; Lamivudine; Male; Middle Aged; Platelet Count; Predictive Value of Tests; Reverse Transcriptase Inhibitors; Survival Analysis | 2002 |
Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Bilirubin; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Failure, Acute; Male; Middle Aged; Prothrombin Time | 2006 |
High rates of progressive hepatic functional deterioration whether lamivudine therapy is continued or discontinued after emergence of a lamivudine-resistant mutant: a prospective randomized controlled study.
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Bilirubin; Biomarkers; Disease Progression; DNA, Viral; Drug Resistance, Viral; Female; Follow-Up Studies; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Korea; Lamivudine; Liver Failure; Male; Middle Aged; Multivariate Analysis; Mutation; Platelet Count; Predictive Value of Tests; Prospective Studies; Prothrombin Time; Reverse Transcriptase Inhibitors; Risk Factors; Serum Albumin | 2006 |
A randomized controlled trial of lamivudine to treat acute hepatitis B.
Topics: Acute Disease; Adolescent; Adult; Aged; Bilirubin; Child; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Immunocompetence; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Treatment Outcome | 2007 |
Adefovir dipivoxil treatment of lamivudine-resistant chronic hepatitis B.
Topics: Adenine; Adult; Aged; Alanine Transaminase; Antibodies, Viral; Antiviral Agents; Bilirubin; Creatinine; DNA, Viral; Drug Resistance, Viral; Female; Genotype; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Reverse Transcriptase Inhibitors; Time Factors; Treatment Outcome; Viral Load | 2007 |
The study of efficacy of lamivudine in patients with severe acute hepatitis B.
Topics: Acute Disease; Adult; Aged; Anti-HIV Agents; Bilirubin; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Failure; Male; Middle Aged; Proportional Hazards Models | 2010 |
Open-label randomized multicenter selection study of once daily antiretroviral treatment regimen comparing ritonavir-boosted atazanavir to efavirenz with fixed-dose abacavir and lamivudine.
Topics: Acquired Immunodeficiency Syndrome; Adult; Alanine Transaminase; Alkynes; Anti-Retroviral Agents; Atazanavir Sulfate; Benzoxazines; Bilirubin; Cholesterol; Cyclopropanes; Dideoxynucleosides; Dose-Response Relationship, Drug; Drug Therapy, Combination; Follow-Up Studies; HIV Infections; Humans; Japan; Lamivudine; Oligopeptides; Pyridines; Ritonavir; Treatment Outcome | 2011 |
Treatment of severe, nonfulminant acute hepatitis B with lamivudine vs placebo: a prospective randomized double-blinded multicentre trial.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Bilirubin; DNA, Viral; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Middle Aged; Placebos; Prospective Studies; Treatment Outcome | 2014 |
17 other study(ies) available for lamivudine and bilirubin
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Effectiveness of lamivudine in treatment of acute recurrent hepatitis B after liver transplantation.
Topics: Acute Disease; Bilirubin; DNA, Viral; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Postoperative Complications; Recurrence; Reverse Transcriptase Inhibitors; Transaminases | 1998 |
Elevated alpha-fetoprotein levels in hepatocellular carcinoma.
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; alpha-Fetoproteins; Anti-HIV Agents; Antiviral Agents; Aspartate Aminotransferases; Bilirubin; Carcinoma, Hepatocellular; Diagnosis, Differential; Hepatitis B, Chronic; Humans; Lamivudine; Liver Neoplasms; Male | 1999 |
Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B.
Topics: Bilirubin; DNA, Viral; Female; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Reverse Transcriptase Inhibitors; Survival Rate; Treatment Outcome; Virus Replication | 2000 |
Lamivudine therapy for spontaneously occurring severe acute exacerbation in chronic hepatitis B virus infection: a preliminary study.
Topics: Acute Disease; Adult; Alanine Transaminase; Bilirubin; DNA, Viral; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Pilot Projects; Prothrombin Time; Reverse Transcriptase Inhibitors | 2001 |
Fatal hepatitis B reactivation following discontinuation of nucleoside analogues for chronic hepatitis B.
Topics: 2-Aminopurine; Adult; Aged; Alanine Transaminase; Antiviral Agents; Bilirubin; DNA, Viral; Drug Resistance, Viral; Famciclovir; Fatal Outcome; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Mutation; Recurrence; Virus Activation | 2002 |
The effect of lamivudine therapy in hepatic decompensation during acute exacerbation of chronic hepatitis B.
Topics: Adult; Bilirubin; Drug Administration Schedule; Female; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Male; Middle Aged; Odds Ratio; Reverse Transcriptase Inhibitors; Survival Analysis | 2003 |
Lamivudine treatment in patients with hepatitis B virus induced liver cirrhosis.
Topics: Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Bilirubin; DNA, Viral; Female; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Reverse Transcriptase Inhibitors; Serum Albumin; Treatment Outcome | 2003 |
Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP.
Topics: Adult; Alanine Transaminase; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bilirubin; Cyclophosphamide; DNA-Directed DNA Polymerase; DNA, Viral; Doxorubicin; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, B-Cell; Male; Mutation; Prednisone; Recurrence; Reverse Transcriptase Inhibitors; Rituximab; Sequence Analysis, DNA; Vincristine; Virus Activation | 2004 |
Lamivudine monotherapy for spontaneous severe acute exacerbation of chronic hepatitis B.
Topics: Acute Disease; Administration, Oral; Adult; Bilirubin; Biomarkers; Disease Progression; DNA, Viral; Female; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Liver Failure, Acute; Male; Middle Aged; Prognosis; Radiography; Recurrence; Retrospective Studies; Reverse Transcriptase Inhibitors; Severity of Illness Index; Transaminases; Treatment Outcome; Ultrasonography | 2005 |
Virological and biochemical relapse after discontinuation of lamivudine monotherapy for chronic hepatitis B in Japan: comparison with breakthrough hepatitis during long-term treatment.
Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; Bilirubin; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Japan; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Mutation; Promoter Regions, Genetic; Recurrence; Retrospective Studies; Risk Factors; Treatment Outcome | 2005 |
Switching to adefovir monotherapy after emergence of lamivudine-resistant mutations in patients with liver cirrhosis.
Topics: Adenine; Adult; Aged; Alanine Transaminase; Antiviral Agents; Bilirubin; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Organophosphonates; Serum Albumin; Statistics, Nonparametric | 2006 |
[Acute hepatitis B: is antiviral therapy indicated? Two case reports].
Topics: Acute Disease; Adenine; Adult; Algorithms; Antiviral Agents; Bilirubin; DNA, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver; Middle Aged; Organophosphonates; Prothrombin Time; Transaminases; Treatment Failure; Treatment Outcome | 2008 |
Predictive factors associated with the progression to hepatic failure caused by lamivudine-resistant HBV.
Topics: Adenine; Adult; Antiviral Agents; Bilirubin; Disease Progression; Drug Resistance, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Failure; Male; Middle Aged; Multivariate Analysis; Organophosphonates; Patient Selection; Predictive Value of Tests; Prognosis; Prothrombin Time; Retrospective Studies; Treatment Outcome | 2008 |
Determinants of the clinical outcome of patients with severe acute exacerbation of chronic hepatitis B virus infection.
Topics: Adult; Alanine Transaminase; Bilirubin; Disease Progression; Disseminated Intravascular Coagulation; DNA, Viral; Female; Glucocorticoids; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Jaundice; Lamivudine; Male; Middle Aged; Prognosis; Prospective Studies; Prothrombin; Treatment Outcome; Viral Load; Young Adult | 2012 |
Combination lamivudine and adefovir versus entecavir for the treatment of naïve chronic hepatitis B patients: a pilot study.
Topics: Adenine; Adult; Alanine Transaminase; Analysis of Variance; Aspartate Aminotransferases; Bilirubin; Drug Combinations; Enzyme-Linked Immunosorbent Assay; Female; Guanine; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Organophosphonates; Pilot Projects | 2013 |
Expression and clinical significance of myeloid derived suppressor cells in chronic hepatitis B patients.
Topics: Adult; Alanine Transaminase; Albumins; Aspartate Aminotransferases; Bilirubin; DNA, Viral; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Leukocytes, Mononuclear; Male; Myeloid Cells | 2014 |